We tested a single nucleotide polymorphism (SNP) in the BACE1 gene to evaluate the genetic influence on BACE1 activity, levels of Aβ40, Aβ42, α- and β-cleaved soluble APP (α-sAPP and β-sAPP) in CSF from AD patients. Here, BACE1 is linked to Alzheimer disease.